Company registration number 01868298 (England and Wales)
HEMSEC MANUFACTURING LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 DECEMBER 2024
HEMSEC MANUFACTURING LIMITED
COMPANY INFORMATION
Directors
W K Hemmings
F Cirafici
(Appointed 17 October 2025)
T Kay
(Appointed 17 October 2025)
Company number
01868298
Registered office
509 - 510 Cotton Exchange
Bixteth Street
Liverpool
L3 9LQ
Auditor
Lonsdale & Marsh
509 - 510 Cotton Exchange
Bixteth Street
Liverpool
L3 9LQ
Business address
Stoney Lane
Rainhill
Prescot
Merseyside
L35 9LL
HEMSEC MANUFACTURING LIMITED
CONTENTS
Page
Strategic report
1 - 3
Directors' report
4
Directors' responsibilities statement
5
Independent auditor's report
6 - 8
Statement of income and retained earnings
9
Balance sheet
10
Notes to the financial statements
11 - 24
HEMSEC MANUFACTURING LIMITED
STRATEGIC REPORT
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 1 -
The directors present the strategic report for the period ended 30 December 2024.
During the period under review, the Company’s principal activity was the manufacture and distribution of high-performance structural insulated panels.
Review of the business
Hemsec Manufacturing Limited is a family-owned company that has been a reputable manufacturer within the construction industry since 1928, celebrating 96 years of trading this period.
The company operates two core product ranges across two manufacturing sites. Steel manufacturing is based at the Rainhill site, while SIPs manufacturing takes place at the Huyton facility. Hemsec serves a diverse customer base across multiple industries and building types, particularly where energy efficiency and thermal performance are critical.
The business benefits from a broad and diversified revenue stream, supporting customers in both residential and commercial sectors.
Hemsec is proud to hold the ‘Made in Britain’ trademark and is accredited to ISO 9001:2015 standards, certified by BRE Global Ltd, reflecting its commitment to quality and operational excellence.
Principal risks and uncertainties
The Board has undertaken a review of the principal risks and uncertainties facing the Company and considers the following to be the most significant factors that may impact performance, financial position, and future prospects.
Market and Economic Risks
The Company operates within the construction sector and is therefore exposed to fluctuations in market demand. Changes in economic conditions, including interest rate movements and inflationary pressures, may influence customer spending and the timing of projects. In addition, delays or cancellations of construction projects could reduce order volumes and impact revenue.
Mitigation:
The Company maintains a diversified customer base across multiple sectors and end markets, reducing reliance on any single segment. Market trends are monitored closely to enable proactive planning and adjustment of production levels.
Input Cost and Supply Chain Risks
The Company is exposed to volatility in the cost and availability of key raw materials, including steel, chemicals and insulation components. Increases in input costs or disruptions within the supply chain may adversely affect margins and production schedules.
Mitigation:
The Company works closely with established suppliers to ensure continuity of supply and regularly reviews pricing. Where possible, cost increases are managed through pricing strategies and operational efficiencies.
Operational Risks
The Company’s manufacturing activities are dependent on the efficient operation of its production facilities. Equipment failure, unplanned downtime, or process inefficiencies could impact production capacity and the ability to meet customer delivery commitments.
Mitigation:
A planned preventative maintenance programme is in place across all sites, supported by ongoing investment in plant and equipment. Operational performance is monitored regularly to identify and address potential issues promptly.
HEMSEC MANUFACTURING LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 2 -
Financial Risks
The Company is exposed to financial risks including interest rate fluctuations, which may affect borrowing costs, and credit risk arising from customer non-payment. Liquidity risk is also monitored to ensure the Company can meet its financial obligations as they fall due.
Mitigation:
The Company maintains appropriate financial controls, including regular cash flow forecasting and credit control procedures. Borrowing arrangements are reviewed periodically to ensure they remain suitable for the Company’s needs.
Regulatory and Compliance Risks
The Company operates within a regulated environment and must comply with relevant building standards, quality certifications, and environmental requirements. Failure to meet these obligations could result in reputational damage or financial penalties.
Mitigation:
The Company maintains ISO 9001:2015 accreditation and adheres to established quality management systems. Regulatory developments are monitored to ensure ongoing compliance.
People and Resource Risks
The Company’s performance depends on the skills and experience of its workforce. Challenges in recruiting and retaining suitably qualified personnel could impact operational efficiency and growth.
Mitigation:
The Company invests in training and development and seeks to maintain a positive working environment to support employee retention and engagement.
The Board believes that the above measures provide a reasonable framework to manage the risks faced by the Company; however, it recognises that no system of control can eliminate risk entirely.
Development and performance
The Company continues to build on its established strengths, with a clear focus on its core products and markets, which have underpinned the business over many years. Maintaining this focus remains central to the Company’s strategy for sustainable growth and long-term value creation.
Alongside this, the Company is committed to strengthening its position within the manufacturing and construction sectors. Ongoing investment in product development and market research supports the identification of opportunities to introduce complementary products that align with the existing portfolio and evolving customer requirements.
During the period, the structural insulated panel (SIPs) market experienced a gradual increase in activity. However, continued delays in policy development relating to modern methods of construction (MMC) have limited the pace of growth within this sector, presenting ongoing challenges in increasing capacity utilisation and revenue.
The Company remains actively engaged in supporting the advancement of MMC and is well positioned to respond as the market develops. At the same time, it continues to maintain a strong and consistent performance within its established steel insulated panel market, ensuring a balanced and resilient approach across its product ranges.
The Company recognises that its employees are fundamental to its continued success. The skill, experience, and commitment of the workforce play a critical role in enabling the Company to achieve its strategic objectives and deliver consistent performance.
The Company remains committed to fostering a positive and supportive working environment, where employees are encouraged to develop their skills and contribute to the ongoing success of the business. Investment in training and development continues to be a priority, ensuring that the workforce is equipped to meet both current operational demands and future challenges.
HEMSEC MANUFACTURING LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 3 -
Key performance indicators
Key performance indicators monitored by the Board include turnover, gross margin, production volumes, and capacity utilisation. While turnover remained broadly in line with expectations, margin performance continued to be influenced by input cost pressures and market pricing dynamics. Production volumes and capacity utilisation improved modestly during the year, reflecting a gradual recovery in demand.
The Board remains confident that the Company’s balanced approach—combining operational discipline, market focus, and strategic development—positions it well for future growth as sector conditions continue to evolve.
The Board also acknowledges the continued efforts of all employees and recognises their importance in achieving the Company’s goals and long-term growth.
F Cirafici
Director
5 May 2026
HEMSEC MANUFACTURING LIMITED
DIRECTORS' REPORT
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 4 -
The directors present their annual report and financial statements for the period ended 30 December 2024.
Principal activities
The principal activity of the company continues to be that of the manufacture of insulated panels and associated products.
Results and dividends
The results for the period are set out on page 9.
No ordinary dividends were paid. The directors do not recommend payment of a final dividend.
Directors
The directors who held office during the period and up to the date of signature of the financial statements were as follows:
W K Hemmings
S J Painter
(Resigned 30 September 2024)
D J Morton
(Appointed 1 April 2024 and resigned 10 October 2025)
I W Aitchison
(Appointed 1 October 2024 and resigned 9 October 2025)
F Cirafici
(Appointed 17 October 2025)
T Kay
(Appointed 17 October 2025)
Auditor
In accordance with the company's articles, a resolution proposing that Lonsdale & Marsh be reappointed as auditor of the company will be put at a General Meeting.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
On behalf of the board
F Cirafici
Director
5 May 2026
HEMSEC MANUFACTURING LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 5 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The directors are responsible for the maintenance and integrity of the company website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
HEMSEC MANUFACTURING LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF HEMSEC MANUFACTURING LIMITED
- 6 -
Opinion
We have audited the financial statements of Hemsec Manufacturing Limited (the 'company') for the period ended 30 December 2024 which comprise the statement of income and retained earnings, the balance sheet and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 30 December 2024 and of its loss for the period then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial period for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
HEMSEC MANUFACTURING LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF HEMSEC MANUFACTURING LIMITED (CONTINUED)
- 7 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intends to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
We obtained an understanding of the legal and regulatory frameworks that are applicable to the company and determined that the most significant are those that relate to Health and Safety and those laws and regulations that have a direct impact on the financial statements such as the Companies Act 2006.
Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, included the following:
the engagement partner ensured the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
discussions with senior management;
identified laws and regulations were communicated within the audit team who remained alert to instances of non-compliance throughout the audit.
We evaluated management’s incentives and opportunities for fraudulent manipulation of the financial statements (including override of controls) and addressed the risk through:
making enquires of those charged with governance as to their knowledge of actual, suspected and alleged instances of fraud;
considering the internal controls in place to mitigate the risks of fraud.
HEMSEC MANUFACTURING LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF HEMSEC MANUFACTURING LIMITED (CONTINUED)
- 8 -
In response to the risk of irregularities and non-compliance with laws and regulations, we designed our audit procedures which included, but was not limited to:
agreeing financial statement disclosures to underlying supporting documentation;
reviewing the minutes of meetings of those charged with governance;
reviewing for any transactions undertaken with related parties such as directors;
discussions with management about any known or suspected instances of non-compliance with laws and regulations;
testing of journals;
analytical review to identify unusual transactions;
checking expenses are bona fide transactions of the company.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulations. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Nicholas James O'Donovan (Senior Statutory Auditor)
For and on behalf of Lonsdale & Marsh, Statutory Auditor
Chartered Accountants
509 - 510 Cotton Exchange
Bixteth Street
Liverpool
L3 9LQ
5 May 2026
HEMSEC MANUFACTURING LIMITED
STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 9 -
Period ended
Period ended
30 December
31 December
2024
2023
Notes
£
£
Turnover
3
12,514,175
17,322,682
Cost of sales
(9,266,193)
(13,508,624)
Gross profit
3,247,982
3,814,058
Distribution costs
(223,094)
(269,043)
Administrative expenses
(3,050,766)
(4,003,766)
Operating loss
4
(25,878)
(458,751)
Interest receivable and similar income
7
8,334
7,711
Interest payable and similar expenses
8
(120,356)
(83,763)
Loss before taxation
(137,900)
(534,803)
Tax on loss
9
45,962
169,079
Loss for the financial period
(91,938)
(365,724)
Retained earnings brought forward
2,715,472
3,081,196
Retained earnings carried forward
2,623,534
2,715,472
The profit and loss account has been prepared on the basis that all operations are continuing operations.
HEMSEC MANUFACTURING LIMITED
BALANCE SHEET
AS AT 30 DECEMBER 2024
30 December 2024
- 10 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
11
1,627,655
1,728,200
1,627,655
1,728,200
Current assets
Stocks
12
536,190
442,553
Debtors
13
5,237,900
4,122,150
Cash at bank and in hand
733,335
725,489
6,507,425
5,290,192
Creditors: amounts falling due within one year
14
(2,830,176)
(2,732,905)
Net current assets
3,677,249
2,557,287
Total assets less current liabilities
5,304,904
4,285,487
Creditors: amounts falling due after more than one year
15
(2,395,390)
(1,132,072)
Provisions for liabilities
18
(285,880)
(437,843)
Net assets
2,623,634
2,715,572
Capital and reserves
Called up share capital
21
100
100
Profit and loss reserves
2,623,534
2,715,472
Total equity
2,623,634
2,715,572
The financial statements were approved by the board of directors and authorised for issue on 5 May 2026 and are signed on its behalf by:
F Cirafici
Director
Company Registration No. 01868298
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 11 -
1
Accounting policies
Company information
Hemsec Manufacturing Limited is a company limited by shares incorporated in England and Wales. The registered office is 509 - 510 Cotton Exchange, Bixteth Street, Liverpool, L3 9LQ. The principal place of business is Stoney Lane, Rainhill, Prescot, Merseyside, L35 9LL.
1.1
Reporting period
These financial statements are for the 12 month period ended 30 December 2024. The previous financial statements were for the 18 month period ended 31 December 2023. As such, the comparative amounts presented in the financial statements (including the related notes) are not entirely comparable. The change in the reporting period was due to less demanding manufacturing requirements during the December period.
1.2
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.
This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:
Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’: Interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
Section 26 ‘Share based Payment’: Share-based payment expense charged to profit or loss, reconciliation of opening and closing number and weighted average exercise price of share options, how the fair value of options granted was measured, measurement and carrying amount of liabilities for cash-settled share-based payments, explanation of modifications to arrangements;
Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.
The financial statements of the company are consolidated in the financial statements of C. Hemmings & Co. Limited. These consolidated financial statements are available from its registered office, c/o Lonsdale & Marsh, 509-510 Cotton Exchange, Bixteth Street, Liverpool, L3 9LQ.
1.3
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.4
Turnover
Turnover represents amounts receivable for goods and services net of VAT and trade discounts. Revenue is recognised upon delivery of goods to the customer.
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
1
Accounting policies
(Continued)
- 12 -
1.5
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date if the fair value can be measured reliably.
1.6
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Land and buildings Leasehold
20% on cost
Plant and machinery
10% - 20% on cost
Fixtures, fittings & equipment
20% - 33% on cost
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.7
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
1.8
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
At each reporting date, an assessment is made for any obsolete, damaged or slow moving stock.
1.9
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
1
Accounting policies
(Continued)
- 13 -
1.10
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors and any loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
1
Accounting policies
(Continued)
- 14 -
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.11
Derivatives
Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to fair value at each reporting end date. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.
A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.
1.12
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
1
Accounting policies
(Continued)
- 15 -
1.13
Provisions
Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
1.14
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.15
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.16
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
1.17
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 16 -
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
3
Turnover and other revenue
An analysis of the company's turnover is as follows:
2024
2023
£
£
Turnover analysed by geographical market
UK
12,131,116
16,557,267
Europe and Ireland
383,059
765,415
12,514,175
17,322,682
2024
2023
£
£
Other significant revenue
Interest income
8,334
7,711
4
Operating loss
2024
2023
Operating loss for the period is stated after charging:
£
£
Exchange losses
5,884
5,098
Fees payable to the company's auditor for the audit of the company's financial statements
12,000
18,000
Depreciation of tangible fixed assets
209,504
276,845
Operating lease charges
4,881
7,620
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 17 -
5
Employees
The average monthly number of persons (including directors) employed by the company during the period was:
2024
2023
Number
Number
Manufacturing
33
29
Sales
7
9
Admin and directors
8
11
Total
48
49
Their aggregate remuneration comprised:
2024
2023
£
£
Wages and salaries
1,999,439
2,421,033
Social security costs
198,423
263,116
Pension costs
75,576
175,563
2,273,438
2,859,712
6
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
312,218
581,187
Company pension contributions to defined contribution schemes
15,091
11,009
327,309
592,196
The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 1 (2023 - 3).
Remuneration disclosed above include the following amounts paid to the highest paid director:
2024
2023
£
£
Remuneration for qualifying services
222,250
219,000
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 18 -
7
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest on bank deposits
8,334
6,250
Interest on the net defined benefit asset
1,461
Total income
8,334
7,711
8
Interest payable and similar expenses
2024
2023
£
£
Interest on bank overdrafts and loans
60,093
59,030
Interest payable to group undertakings
15,481
14,697
Interest on finance leases and hire purchase contracts
44,782
10,036
120,356
83,763
9
Taxation
2024
2023
£
£
Current tax
Adjustments in respect of prior periods
(112,798)
Deferred tax
Origination and reversal of timing differences
(13,297)
234,518
Tax losses carried forward
(32,665)
(290,799)
Total deferred tax
(45,962)
(56,281)
Total tax credit
(45,962)
(169,079)
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
9
Taxation
(Continued)
- 19 -
The actual credit for the period can be reconciled to the expected credit for the period based on the profit or loss and the standard rate of tax as follows:
2024
2023
£
£
Loss before taxation
(137,900)
(534,803)
Expected tax credit based on the standard rate of corporation tax in the UK of 25% (2023: 25%)
(34,475)
(133,701)
Effects of:
Expenses that are not deductible in determining taxable profit
(11,487)
(229,423)
Unutilised tax losses carried forward
290,799
Change in corporation tax rate
16,044
Tax losses carried back
(112,798)
Taxation credit in the financial statements
(45,962)
(169,079)
10
Intangible fixed assets
Development Costs
£
Cost
At 1 January 2024
35,000
Disposals
(35,000)
At 30 December 2024
Amortisation and impairment
At 1 January 2024
35,000
Disposals
(35,000)
At 30 December 2024
Carrying amount
At 30 December 2024
At 31 December 2023
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 20 -
11
Tangible fixed assets
Land and buildings Leasehold
Plant and machinery
Fixtures, fittings & equipment
Total
£
£
£
£
Cost
At 1 January 2024
611,251
1,942,925
336,990
2,891,166
Additions
13,851
18,481
76,627
108,959
At 30 December 2024
625,102
1,961,406
413,617
3,000,125
Depreciation and impairment
At 1 January 2024
94,068
776,096
292,802
1,162,966
Depreciation charged in the period
64,630
113,086
31,788
209,504
At 30 December 2024
158,698
889,182
324,590
1,372,470
Carrying amount
At 30 December 2024
466,404
1,072,224
89,027
1,627,655
At 31 December 2023
517,183
1,166,829
44,188
1,728,200
Included within tangible fixed assets are assets held under finance leases or hire purchase contracts, as follows:
2024
2023
£
£
Plant and machinery
489,120
344,993
Fixtures, fittings & equipment
46,214
535,334
344,993
12
Stocks
2024
2023
£
£
Raw materials and consumables
404,525
288,022
Finished goods and goods for resale
131,665
154,531
536,190
442,553
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 21 -
13
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
1,663,348
1,534,766
Corporation tax recoverable
112,798
112,798
Other debtors
57,919
52,623
Prepayments and accrued income
3,080,371
2,131,164
4,914,436
3,831,351
2024
2023
Amounts falling due after more than one year:
£
£
Deferred tax asset (note 19)
323,464
290,799
Total debtors
5,237,900
4,122,150
14
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Bank loans
16
270,270
200,000
Obligations under finance leases
17
254,012
106,750
Other borrowings
16
54,517
45,431
Trade creditors
1,899,746
2,018,839
Taxation and social security
105,963
126,965
Other creditors
14,637
10,566
Accruals and deferred income
231,031
224,354
2,830,176
2,732,905
15
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Bank loans and overdrafts
16
1,116,216
300,000
Obligations under finance leases
17
1,101,993
604,916
Other borrowings
16
177,181
227,156
2,395,390
1,132,072
The bank loan is secured by a cross guarantee with C. Hemmings & Co. Limited, the ultimate parent company.
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 22 -
16
Loans and overdrafts
2024
2023
£
£
Bank loans
1,386,486
500,000
Loans from group undertakings
231,698
272,587
1,618,184
772,587
Payable within one year
324,787
245,431
Payable after one year
1,293,397
527,156
Bank loans are repayable by instalments.
Interest is calculated as follows:
The bank borrowing is secured as follows:
a debenture in favour of a lender creating a fixed and floating charge over all its present and future assets.
by a cross guarantee with C. Hemmings & Co. Limited, the ultimate parent company.
17
Finance lease obligations
2024
2023
Amounts due:
£
£
Within one year
254,012
106,750
After more than one year
1,101,993
604,916
1,356,005
711,666
2024
2023
Future minimum lease payments due:
£
£
Within one year
254,012
106,750
In two to five years
993,143
426,999
In over five years
108,850
177,917
1,356,005
711,666
Finance lease payments represent rentals payable by the company for certain items of plant and machinery and computer equipment. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 6 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 23 -
18
Provisions for liabilities
2024
2023
£
£
Dilapidations
-
138,666
Movements on provisions:
Dilapidations
£
At 1 January 2024
138,666
Utilisation of provision
(138,666)
At 30 December 2024
-
The dilapidation provision relates to expected costs of making good all infrastructure added to the new facility at the end of the lease, along with repairs to existing infrastructure.
19
Deferred taxation
Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:
Liabilities
Liabilities
Assets
Assets
2024
2023
2024
2023
Balances:
£
£
£
£
Accelerated capital allowances
285,880
299,177
-
-
Tax losses
-
-
323,464
290,799
285,880
299,177
323,464
290,799
2024
Movements in the period:
£
Liability at 1 January 2024
8,378
Credit to profit or loss
(45,962)
Asset at 30 December 2024
(37,584)
The deferred tax asset set out above is expected to reverse within the next few years and relates to the utilisation of tax losses against future expected profits of the same period. The deferred tax liability set out above is expected to reverse over a number of years and relates to accelerated capital allowances that are expected to mature over the same period.
HEMSEC MANUFACTURING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2024
- 24 -
20
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
75,576
175,563
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
21
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
22
Operating lease commitments
As lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
2024
2023
£
£
Within 1 year
498,063
492,276
Years 2-5
1,968,916
1,925,574
After 5 years
1,040,000
1,520,000
3,506,979
3,937,850
23
Capital commitments
Amounts contracted for but not provided in the financial statements:
2024
2023
£
£
Acquisition of tangible fixed assets
-
375,000
24
Ultimate controlling party
The ultimate parent company is C.Hemmings & Co. Limited, the registered office of which is 509 - 510 Cotton Exchange, Bixteth Street, Liverpool, L3 9LQ.
The financial statements of the company are consolidated in the financial statements of C. Hemmings & Co. Limited. These consolidated financial statements are available from its registered office and Companies House.
2024-12-302024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100W K HemmingsS J PainterD J MortonI W AitchisonF CiraficiT Kay018682982024-01-012024-12-3001868298bus:Director12024-01-012024-12-3001868298bus:Director52024-01-012024-12-3001868298bus:Director62024-01-012024-12-3001868298bus:Director22024-01-012024-12-3001868298bus:Director32024-01-012024-12-3001868298bus:Director42024-01-012024-12-3001868298bus:RegisteredOffice2024-01-012024-12-30018682982024-12-30018682982022-07-012023-12-3101868298core:RetainedEarningsAccumulatedLosses2023-12-3101868298core:RetainedEarningsAccumulatedLosses2022-06-3001868298core:RetainedEarningsAccumulatedLosses2024-12-3001868298core:RetainedEarningsAccumulatedLosses2023-12-3101868298core:ShareCapital2024-12-3001868298core:ShareCapital2023-12-31018682982023-12-3101868298core:ShareCapitalOrdinaryShareClass12024-12-3001868298core:ShareCapitalOrdinaryShareClass12023-12-3101868298core:CurrentFinancialInstruments2024-12-3001868298core:CurrentFinancialInstruments2023-12-3101868298core:Non-currentFinancialInstruments2024-12-3001868298core:Non-currentFinancialInstruments2023-12-3101868298core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3001868298core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3101868298core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3001868298core:LandBuildingscore:LongLeaseholdAssets2024-01-012024-12-3001868298core:PlantMachinery2024-01-012024-12-3001868298core:FurnitureFittings2024-01-012024-12-3001868298core:UKTax2024-01-012024-12-3001868298core:UKTax2022-07-012023-12-310186829812024-01-012024-12-300186829812022-07-012023-12-3101868298core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-3101868298core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-3001868298core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-012024-12-3001868298core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-3101868298core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-12-3101868298core:PlantMachinery2023-12-3101868298core:FurnitureFittings2023-12-31018682982023-12-3101868298core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-12-3001868298core:PlantMachinery2024-12-3001868298core:FurnitureFittings2024-12-3001868298core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-01-012024-12-3001868298core:LandBuildings2023-12-3101868298core:PlantMachinery2023-12-3101868298core:FurnitureFittings2023-12-3101868298core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3001868298core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3101868298core:WithinOneYear2024-12-3001868298core:WithinOneYear2023-12-3101868298core:BetweenTwoFiveYears2024-12-3001868298core:BetweenTwoFiveYears2023-12-3101868298core:MoreThanFiveYears2024-12-3001868298core:MoreThanFiveYears2023-12-3101868298bus:OrdinaryShareClass12024-01-012024-12-3001868298bus:OrdinaryShareClass12024-12-3001868298bus:OrdinaryShareClass12023-12-3101868298bus:PrivateLimitedCompanyLtd2024-01-012024-12-3001868298bus:FRS1022024-01-012024-12-3001868298bus:Audited2024-01-012024-12-3001868298bus:FullAccounts2024-01-012024-12-30xbrli:purexbrli:sharesiso4217:GBP